Table of Contents
<< Previous Issue | May 2016 (Vol: 2016, Issue: 5) | Next Issue >> |
- Section: Licensing
-
Ionis Pharmaceuticals Selects Kastle Therapeutics as its New Commercial Partner for Kynamro®
-
Janssen Biotech Adds Tesaro’s Niraparib to its Prostate Cancer Portfolio in a US$500 M Deal
-
Pfizer and WAVE Collaborate to Develop Metabolic Therapies
- Section: Mergers & Acquisitions
-
AbbVie’s Deal Spree Enriches its Pipeline with Oncology Assets